| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/06/2008 | CN100408574C Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 08/06/2008 | CN100408561C 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
| 08/06/2008 | CN100408550C Method for synthesizing camptothecin-relating compounds |
| 08/06/2008 | CN100408099C Oral pharmaceutical composition containing a block copolymer |
| 08/05/2008 | US7408008 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 08/05/2008 | US7407988 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 08/05/2008 | US7407985 Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments |
| 08/05/2008 | US7407975 Epothilone derivatives, method for producing same and their pharmaceutical use |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | CA2392903C Trans olefinic glucokinase activators |
| 08/05/2008 | CA2388470C Use of carbonylamino derivatives against cns disorders |
| 08/05/2008 | CA2337098C Anthranilic acid derivatives |
| 08/05/2008 | CA2290617C Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp |
| 07/31/2008 | WO2008092072A2 Modulators of the metabotropic glutamate receptor subtype 5 and uses thereof |
| 07/31/2008 | WO2008091818A1 Substituted arylcyclopentenes as therapeutic agents |
| 07/31/2008 | WO2008091681A2 Theramutein modulators |
| 07/31/2008 | WO2008073687A3 Compounds and compositions as protein kinase inhibitors |
| 07/31/2008 | WO2008070306A2 1,5-diphenyl-3-benzylamin0-1,5-dihydr0pyrr0lidin-2-0ne as cb1 receptor modulators |
| 07/31/2008 | WO2008061236A3 Sulfoximines as kinase inhibitors |
| 07/31/2008 | WO2008057775A3 Heterocyclic amide compounds useful as kinase inhibitors |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/31/2008 | US20080182842 L-alanine derivatives as a5beta1 antagonists |
| 07/31/2008 | US20080182837 New chemical compounds |
| 07/31/2008 | CA2676252A1 Substituted arylcyclopentenes as therapeutic agents |
| 07/30/2008 | EP1949896A2 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/30/2008 | EP1948629A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 07/30/2008 | EP1948622A1 Tricyclo substituted amides as glucokinase modulators |
| 07/30/2008 | EP1948609A1 Process for the preparation of pyridylcarboxylic amides and esters |
| 07/30/2008 | EP1948608A2 Pharmaceutical salts and polymorphs of n-(5-chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxy-benzamide , a factor xa inhibitor |
| 07/30/2008 | EP1601652B1 Pyridinium salts, compounds and methods of use |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | CN101233110A Substance with oxidation resistance, agedness protection and anti-ischemia active and preparing method thereof |
| 07/30/2008 | CN101230368A Isolation and purification method for lactarius vellereus |
| 07/30/2008 | CN101230038A Pyridine carboxamide derivatives and their use as pesticides |
| 07/30/2008 | CN101230037A Anti-cancer drug compounds and method for synthesizing same |
| 07/30/2008 | CN101230036A Method for preparing heterocyclic aryl-aryl biphenyl compounds |
| 07/30/2008 | CN100406442C 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents |
| 07/30/2008 | CN100406441C Cyclic amine compounds |
| 07/30/2008 | CN100406007C Asthma and allergic inflammation modulators |
| 07/29/2008 | US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 07/29/2008 | US7405229 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 07/29/2008 | US7405226 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 07/29/2008 | CA2359592C Pharmaceutical compositions for alleviating discomfort |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2214323C Compounds and compositions for delivering active agents |
| 07/29/2008 | CA2168192C 4-aminobenzoylguanidine derivatives |
| 07/25/2008 | CA2617463A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/24/2008 | WO2008088540A2 N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases |
| 07/24/2008 | WO2008087736A1 Process for producing aromatic amine having aralkyloxy or heteroaralkyloxy group |
| 07/24/2008 | WO2008087421A2 Male contraceptive |
| 07/24/2008 | WO2008070365A3 Oxidation reaction for producing aromatic carboxylic acids |
| 07/24/2008 | WO2008033328A3 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
| 07/24/2008 | WO2008029217A3 Dipeptidyl peptidase iv inhibitors |
| 07/24/2008 | WO2007127473A3 Poly (ethylene glycol) containing chemically disparate endgroups |
| 07/24/2008 | WO2007120528A3 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases |
| 07/24/2008 | US20080177078 Conversion of 2-Pyrazolines to Pyrazoles Using Bromine |
| 07/24/2008 | US20080177077 Halogenation of methyl 3-(4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate or derivative; reacting with benzyl halide in solvent and base; chemical intermediates of 4-hydroxy-6-methylpyranone and methyl-3-amino-4-methyl benzoate; amidation, etherification, esterification; p38 kinase inhibitor |
| 07/24/2008 | US20080177020 Non-metallocene organometallic complexes and related methods and systems |
| 07/24/2008 | US20080176905 Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
| 07/24/2008 | US20080176903 Novel Compounds with Analgesic Effect |
| 07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/24/2008 | US20080176881 Compounds and compositions as protein kinase inhibitors |
| 07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
| 07/24/2008 | US20080176841 (amidomethyl-amido)-(carboxy/amido)epoxide derivatives; cathepsin inhibitor; antiinflammatory, anticarcinogenic, antidiabeticagent, antiallergen, autoimmune and neurodegenerative disorders |
| 07/24/2008 | US20080176833 Dihydropyridine derivatives as useful as protein kinase inhibitors |
| 07/24/2008 | US20080176763 Collection of Traceable Compounds and Uses Thereof |
| 07/24/2008 | CA2673586A1 N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases |
| 07/23/2008 | EP1947086A1 Benzene derivative or salt thereof |
| 07/23/2008 | EP1945632A1 Heterocyclic modulators of atp-binding cassette transporters |
| 07/23/2008 | EP1945614A1 Process for preparation of chiral amlodipine gentisate |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1675823B1 Phenethanolamine derivatives for the treatment of respiratory diseases |
| 07/23/2008 | EP1671949B1 Substituted Pyridinylamines |
| 07/23/2008 | EP1073638B1 Heterocyclically substituted amides, their production and their use |
| 07/23/2008 | EP0831769B2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 07/23/2008 | CN101228647A Monoamine compound, charge-transporting material, and organic electroluminescent device |
| 07/23/2008 | CN101228129A Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls |
| 07/23/2008 | CN101228128A A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
| 07/23/2008 | CN101228120A HIV reverse transcriptase inhibitors |
| 07/23/2008 | CN101225071A 2-vinylpyridine produced by catalyst distillation of heteropoly acid |
| 07/23/2008 | CN100404529C 2,4-bis (trifluoroethoxy)pyridine compound and drug containing the compound |
| 07/23/2008 | CN100404506C Phenylpyridine iridium metal complex compound and its preparation method |
| 07/22/2008 | US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402690 Chain transfer agents for raft polymerization in aqueous media |
| 07/22/2008 | US7402683 Cinnamic acid amides |
| 07/22/2008 | US7402676 Substituted dihydro 3-halo-1H-pyrazole-5-carboxylates their preparation and use |
| 07/22/2008 | US7402671 UV excitable fluorescent energy transfer dyes |
| 07/22/2008 | US7402598 Arylethanolamine β2-adrenoreceptor agonist compounds |
| 07/22/2008 | US7402586 3-Benzylsulfonylamino-6-methyl-1-[(3-guanidinooxypropyl)aminocarbonylmethyl]-2-pyridinone trifluoroacetate; anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 07/22/2008 | CA2481246C Compounds that modulate ppar activity and methods for their preparation |
| 07/17/2008 | WO2008085064A2 Hydroxypyridinone chelating agents, their metal complexes and their use as mri contrast agents |
| 07/17/2008 | WO2008084872A1 Hydrazone derivative |
| 07/17/2008 | WO2008084671A1 Process for producing 1-substituted-2-pyridone-3-carboxylic acid derivative |
| 07/17/2008 | WO2008084223A2 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
| 07/17/2008 | WO2008084004A1 Sulfonamide derivatives as chymase inhibitors |
| 07/17/2008 | US20080171774 e.g. 2-chloro-N-(3',4'-dichlorobiphenyl-2-yl)nicotinamide; controlling phytopathogenic harmful fungi and plant diseases: Alternaria, Aphanomyces, Bipolaris, Drechslera, Bremia lactucae, Drechslera, Erysiphe cichoracearum, Sphaerotheca fuliginea, Fusarium and Verticillium species |
| 07/17/2008 | US20080171767 N-substituted-2-alkylthio-2-(substituted aryloxy and heteroaryloxy)alkylamides and their sulphinyl and sulphonyl derivatives such as 2-(3,5-dichlorophenoxy)-2-methylthio-N-2-methylprop-2-yl acetamide; fungal infections of plants |